Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $66.8700 (-1.07%) ($66.8700 - $68.3000) on Fri. Dec. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.17% (three month average) | RSI | 59 | Latest Price | $66.8700(-1.07%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWC(47%) IWM(47%) IWN(47%) IWO(46%) IBB(43%) | Factors Impacting LGND price | LGND will decline at least -2.085% in a week (0% probabilities). VXX(-22%) XBI(-16%) SHY(-16%) VCSH(-9%) GLD(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.085% (StdDev 4.17%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $66.75(0.18%) | 10 Day Moving Average | $65.75(1.7%) | 20 Day Moving Average | $65.64(1.87%) | To recent high | -31.3% | To recent low | 8.2% | Market Cap | $1.075b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |